Ninlaro Granted Conditional Approval by European Commission to Treat Multiple Myeloma
The European Commission has granted conditional marketing authorization to…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Nonspecific Symptoms Including Back Pain Should Be Red Flags for Myeloma, Study Suggests
A combination of nonspecific symptoms, including back pain and…
FDA OKs Darzalex as Combination Therapy for Relapsed or Refractory Myeloma Patients
The U.S. Food and Drug Administration (FDA) has approved…
Drug Therapy Combo May Have Led to Toxic Epidermal Necrolysis in Multiple Myeloma Patient
Multiple myeloma patients taking the immunomodulatory drug thalidomide may…
Oral 3-Drug Combo Looks Promising in Treatment-Resistant Myeloma
Combining three well-known oral drugs shows potential for heavily pretreated…
Kyprolis Combo Seen to Improve Life Quality in Relapsed Multiple Myeloma Patients
Adding the proteasome inhibitor Kyprolis (carfilzomib) to the standard…
